Latest News
Kyntra Bio, Inc.
- Kyntra Bio, Inc. Estimates – DUS:1FG0
- Kyntra Bio stock: Maxim initiates coverage for Kyntra Bio stock at USD 35.00
- Kyntra Bio (KYNB): Can Its New Strategy And Pipeline Revive Investor Interest?
- Kyntra Bio stock fell to USD 4.85 on October 16, down 9.5 percent
- Kyntra Bio stock costs EUR 5.00 at a USD 22.6 million market value
- Maxim Group initiates Kyntra Bio stock coverage with buy rating By Investing.com
- Kyntra Bio Inc. (KYNB) Rises 2.52% to $6.11, Testing the Upper Edge of Its Recent Range - Sector ETF Flow
- Kyntra Bio Faces Nasdaq Delisting, Appeals Listing Decision
- Form 4 Kyntra Bio Inc For: 6 October By Investing.com
- Kyntra Bio Received Notice of Delisting
- Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
- Kyntra (KYNB) Stock Screener: -0.58% Decline on Elevated Volume 2026-09-28 - Naked POC
Headlines from the last 30 days, linking to the original publishers. See all market news →